In addition to seeking Novel Food approval in the EU, the company is also seeking GRAS status in the US.

According to a new study on PEKILO®Pet, the alternative protein can help enhance gut microbiome diversity.

Leveraging $39 million in funding, the company’s facility will help meet the need for more sustainable proteins. 

The facility will produce PEKILO® mycoprotein ingredients for the aquaculture, pet food and food industries.

The company plans to expand the use of its PEKILO mycoprotein to encompass aquaculture, pet food and human food.